XML 37 R20.htm IDEA: XBRL DOCUMENT v3.25.3

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2025

Accounting Policies [Abstract]

Schedule of Anti-dilutive Securities

The following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 Schedule of Anti-dilutive Securities

		September 30, 2025 (Unaudited)				September 30, 2024 (Unaudited)
Series L convertible preferred stock 1			7,649,792				—
Options to purchase common stock			597,550				101,264
Warrants to purchase common stock			49,459,390				1,133,762
Total anti-dilutive securities			57,706,732				1,235,026

¹ Converted into common stock using a conversion price of $0.6421 per share, as of September 30, 2025

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration